Clinical-guideline

Clinical Guideline · Assessment & Management of Hypertension

📋 Clinical Guideline · Assessment & Management of Hypertension

A physiology-based approach to triage, phenotyping, and treatment — matching drugs to broken gears.

PART 1 Initial Assessment (The "Physiological Triage")

When a patient presents with elevated BP, our goal is to answer three questions:

  • 1. Is this a crisis (immediate danger)?
  • 2. Is this primary (essential) or secondary (fixable cause)?
  • 3. What is the hemodynamic phenotype (High CO, High TPR, or High Volume)?

Step 1: Confirm the Diagnosis

  • Do not treat based on one reading. Take 2–3 readings, 1–2 minutes apart, patient seated, back supported, feet flat.
  • Confirm with Ambulatory Blood Pressure Monitoring (ABPM) or home readings if clinic BP is high (rule out "White Coat" hypertension).

Step 2: Rule out Hypertensive Emergency (The "Crisis" Triage)

  • Check for target organ damage (TOD): chest pain, dyspnea, neurological changes, back pain (aortic dissection).
  • Exam: fundi for hemorrhages/papilledema, lungs for crackles, check pulses.
  • If TOD is present: Hypertensive Emergency. Lower BP by 20–25% within the first hour using IV agents (Labetalol, Nicardipine). Do NOT drop to normal immediately — risk of cerebral/renal ischemia.

PART 2 Identifying the Physiological Phenotype

Using our cheat sheet, we clinically predict the underlying hemodynamic driver:

Clinical CluePhysiological PredictionLikely Etiology
BP High + HR Fast (>85)High Cardiac Output (Sympathetic drive)Hyperthyroidism, Anemia, Pain/Anxiety, Pheochromocytoma
BP High + HR Normal/SlowHigh TPR or High VolumeEssential HTN, Renal Artery Stenosis, Hyperaldosteronism
Wide Pulse Pressure (e.g., 180/70)Stiff, non-compliant arteries (loss of elastin)Isolated Systolic HTN (Aging / Arteriosclerosis)
Narrow Pulse Pressure (e.g., 130/110)High diastolic resistance + low SVSevere aortic stenosis or pericardial disease
Edema + Bounding PulsesHigh Preload / HypervolemiaHeart Failure, Kidney Failure, Primary Aldosteronism

Step 3: Basic Laboratory & Imaging Workup

  • Blood: Basic Metabolic Panel (Creatinine/eGFR, Na, K), Fasting Glucose, Lipid Panel.
  • Urine: Urinalysis (proteinuria suggests kidney damage).
  • ECG: Check for LVH or ischemia.
  • If secondary HTN suspected (young <30 or resistant):
    • High K⁺ + High BP → CKD or Renal Artery Stenosis.
    • Low K⁺ + High BP → Primary Aldosteronism (Conn's) → Aldosterone/Renin Ratio (ARR).
    • Episodic spikes + Sweating/Pallor → Pheochromocytoma → 24h urine Metanephrines.
    • Cushingoid features → 24h urine Cortisol.

PART 3 Non-Pharmacological Management (The "Physiological Reset")

InterventionPhysiological TargetExpected BP Reduction
Dietary Sodium Restriction (< 2g/day)Reduces extracellular volume, unloads Na/K pump~5–10 mmHg
DASH Diet (Fruits/Vegetables/Low Fat)↑ K⁺, ↑ NO, reduces oxidative stress~10–12 mmHg
Weight Loss (BMI < 25)Reduces sympathetic tone, leptin-mediated outflow~5–20 mmHg
Aerobic Exercise (150 min/week)↑ shear stress → NO release, lowers resting HR~5–8 mmHg
Alcohol ModerationReduces sympathetic activation and volume~4 mmHg

PART 4 Pharmacological Management — Matching Drugs to Physiology

First-line agents (the "Big Four") and their physiological targets:

Drug ClassPhysiological TargetBest For (Phenotype)Mechanism
Thiazide Diuretic (Chlorthalidone)Volume / PreloadElderly, Edema, Heart Failure, High SaltReduces blood volume, lowers CO, restores Na/K pump
ACE Inhibitor (Lisinopril)RAAS / TPRYounger, Diabetics, CKD, High AngiotensinogenBlocks Ang II → dilates arterioles, reduces aldosterone
ARB (Losartan)RAAS / TPRSame as ACEi (for cough intolerance)Blocks AT1 receptor → prevents SR calcium release
Calcium Channel Blocker (Amlodipine)Vascular Smooth Muscle / TPRIsolated Systolic HTN, Black patients, Low-reninBlocks VGCC → prevents calcium influx, relaxes arteriole
Beta-Blocker (Metoprolol)Cardiac Output / HRHigh HR, Angina, Heart Failure, Post-MIReduces HR and contractility → lowers CO

Stepwise Treatment Algorithm

Step 1 (Mild HTN; BP < 150/90): Start 1 drug based on phenotype.

  • High HR/Sympathetic → Beta-blocker
  • Edema/High Volume → Diuretic
  • High TPR/Stiff vessels → CCB or ACEi/ARB

Step 2 (Moderate HTN; BP > 150/90): Start Dual Therapy.

  • Best combo: ACEi/ARB + CCB or ACEi/ARB + Diuretic.
  • Rationale: ACEi lowers TPR, CCB lowers TPR via different pathway → synergistic vasodilation, prevents reflex tachycardia.

Step 3 (Resistant HTN; BP uncontrolled on 3 drugs): Triple Therapy.

  • Add Mineralocorticoid Receptor Antagonist (Spironolactone) — blocks aldosterone effect on kidney and vessels.

Step 4 (Refractory HTN): Evaluate for Renal Artery Stenosis or Pheochromocytoma. Consider Alpha-blockers or direct vasodilators (Hydralazine, Minoxidil) which open K⁺ channels to hyperpolarize and shut VGCC.

PART 5 Special Circumstances

ConditionPhysiological QuirkBest Management
Chronic Kidney Disease (CKD)Failing kidneys → volume overloadACEi/ARB (renal protection) + Diuretic (Furosemide)
Diabetes MellitusHyperglycemia damages endothelium, destroys NO; insulin resistance raises sympathetic toneACEi/ARB (first-line to reduce proteinuria) + CCB
Elderly (>65)Aorta stiff (loss of elastin), wide pulse pressureCCB (Amlodipine) or Diuretic (Chlorthalidone). Avoid Beta-blockers.
PregnancyIncreased volume, but resistance drops; preeclampsia driven by placental factorsMethyldopa or Labetalol. AVOID ACEi/ARBs (fetal renal agenesis).
African-American PatientsGenetically low-renin, salt-sensitiveCCB or Diuretic are superior first-line compared to ACEi alone.

PART 6 Monitoring & Goal Targets

  • General Goal: < 130/80 mmHg (ACC/AHA 2017) for most adults.
  • Elderly (>65): Aim < 130/80 if tolerated, but avoid diastolic < 60 (compromises coronary filling).
  • CKD/Diabetes: < 130/80 mmHg.
⚠️ Physiological Warning: Do not drop BP too fast in long-standing HTN. Their autoregulatory curve has shifted right. Sudden drop to 120/70 can cause acute kidney injury or stroke.

📋 The Final Physiological Cheat Sheet (Clinical Summary)

Assessment FindingBroken GearManagement Strategy
Wide Pulse Pressure + Stiff PulseLarge Arteries (Loss of Elastin)CCB (Amlodipine)
High Diastolic + Normal HRArterioles (High TPR / RAAS)ACEi/ARB (Lisinopril)
Fast HR + Anxiety/SweatingHeart (High CO / Sympathetic)Beta-Blocker (Metoprolol)
Edema + Weight Gain + Low K⁺Kidneys (High Volume / Aldosterone)Spironolactone or Diuretic
Spiking BP + Headache + SweatingAdrenal Medulla (Catecholamines)Alpha-Blocker (Phenoxybenzamine) then Beta-Blocker

🧬 Clinical guideline · physiological phenotyping · stepwise therapy · target organ protection hypertension management · 2026